ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,916Medicare Part D Prescriptions Filled, Including Refills

Rank: 197 out of 1448

$305K Total Retail Price of All Prescriptions

Rank: 334 out of 1448

379 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 5,706 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 507 489 1 3
METOPROLOL SUCCINATE 245 233 2 6
FUROSEMIDE 182 182 3 7
AMLODIPINE BESYLATE 175 168 4 2
HYDROCHLOROTHIAZIDE 172 169 5 18
METOPROLOL TARTRATE 151 147 6 9
CARVEDILOL 143 136 7 1
ATORVASTATIN CALCIUM 141 136 8 4
LISINOPRIL 139 139 9 5
ATENOLOL 130 124 10 12
WARFARIN SODIUM 129 118 11 8
LEVOTHYROXINE SODIUM 125 125 12 21
POTASSIUM CHLORIDE 121 115 13 19
LOSARTAN-HYDROCHLOROTHIAZIDE 114 112 14 38
METFORMIN HCL 107 104 15 25
ISOSORBIDE MONONITRATE ER 103 103 16 16
DIGOXIN 98 92 17 13
TRIAMTERENE-HCTZ 95 95 18 55
LOSARTAN POTASSIUM 86 82 19 11
CLOPIDOGREL 73 73 20 10
BENAZEPRIL HCL 71 67 21 26
SPIRONOLACTONE 68 58 22 24
PLAVIX 67 67 23 14
PROPRANOLOL HCL 67 67 23 105
ZOLPIDEM TARTRATE 67 67 23 34
AMIODARONE HCL 64 62 26 22
OMEPRAZOLE 61 57 27 23
TAMSULOSIN HCL 60 60 28 46
LIPITOR 58 57 29 30
NITROSTAT 50 50 30 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.